schizophrenia
Conditions
Interventions
control group:placebo
Sponsors
Ethics Committee of the Second Affiliated Hospital of Xinxiang Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 55 Years
Inclusion criteria
Inclusion criteria: The attack met the clinical diagnostic criteria of dsm-5 schizophrenia; age: 18-55 years; gender: male to female ratio: 1; course of disease: 1-10 years; all patients did not take antipsychotic drugs in the first half month of the study; PANSS score >= 60, and at least one item was negative; voluntary informed consent was signed.
Exclusion criteria
Exclusion criteria: Suffering from acute (chronic) infectious diseases, serious physical diseases, immune diseases; other types of mental disorders that do not meet the diagnostic criteria of schizophrenia, such as alcohol or drug dependence, bipolar disorder, mental retardation and other mental diseases; recent history of allergy, substance abuse and immunosuppressant use; recent history of vaccination; gastric ulcer, gastrointestinal cancer History of bleeding; pregnant and lactating women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| PANSS;BMI;blood glucose;blood lipid;interleukin 17; | — |
Secondary
| Measure | Time frame |
|---|---|
| tumor necrosis factor a;interleukin 1ß; | — |
Countries
China
Contacts
Public ContactLuxian Lv
The Second Affiliated Hospital of Xinxiang Medical University
Outcome results
None listed